Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kalvista Pharmaceuticals, Inc. (KALV) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kalvista Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1348911.
Total stock buying since 2015: $84,861,482.
Total stock sales since 2015: $87,358,399.
Total stock option exercises since 2015: $2,195,865.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 361,212 | $3,322,932 | 135,028 | $1,885,940 | 152,041 | $0 |
| 2024 | 732,000 | $9,646,480 | 424,144 | $5,659,753 | 476,424 | $0 |
| 2023 | 519,017 | $6,465,649 | 180,807 | $1,783,409 | 302,535 | $131,310 |
| 2022 | 0 | $0 | 14,898 | $197,333 | 71,848 | $440,499 |
| 2021 | 0 | $0 | 308,186 | $8,337,681 | 141,186 | $1,219,726 |
| 2020 | 115,686 | $1,995,814 | 84,358 | $1,507,852 | 358 | $2,412 |
| 2019 | 127,647 | $2,163,687 | 1,420,419 | $37,319,673 | 37,493 | $63,676 |
| 2018 | 1,117,648 | $19,000,016 | 31,288 | $625,999 | 0 | $0 |
| 2017 | 2,265,065 | $19,316,904 | 2,901,930 | $30,003,759 | 0 | $0 |
| 2016 | 0 | $0 | 0 | $0 | 42,429 | $332,642 |
| 2015 | 4,590,000 | $22,950,000 | 10,000 | $37,000 | 10,000 | $5,600 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 33,875 | $448,701 | 72,636 | $0 |
| 2025-07 | 0 | $0 | 63,229 | $992,252 | 0 | $0 |
| 2025-06 | 0 | $0 | 7,169 | $103,950 | 15,625 | $0 |
| 2025-05 | 0 | $0 | 13,256 | $154,817 | 28,141 | $0 |
| 2025-04 | 25,000 | $235,500 | 0 | $0 | 0 | $0 |
| 2025-03 | 0 | $0 | 6,669 | $79,827 | 15,625 | $0 |
| 2025-02 | 280,751 | $2,600,066 | 10,830 | $106,393 | 20,014 | $0 |
| 2025-01 | 55,461 | $487,366 | 0 | $0 | 0 | $0 |
| 2024-12 | 0 | $0 | 7,627 | $74,363 | 15,625 | $0 |
| 2024-11 | 0 | $0 | 33,819 | $315,607 | 68,350 | $0 |
| 2024-09 | 0 | $0 | 7,352 | $89,620 | 15,625 | $0 |
| 2024-08 | 0 | $0 | 33,341 | $402,091 | 68,343 | $0 |
| 2024-06 | 0 | $0 | 7,465 | $86,071 | 15,625 | $0 |
| 2024-05 | 0 | $0 | 54,832 | $645,096 | 119,223 | $0 |
| 2024-02 | 86,048 | $1,257,827 | 239,708 | $3,526,105 | 173,633 | $0 |
| 2024-01 | 645,952 | $8,388,653 | 40,000 | $520,800 | 0 | $0 |
| 2023-12 | 519,017 | $6,465,649 | 30,000 | $360,450 | 0 | $0 |
| 2023-11 | 0 | $0 | 47,871 | $393,927 | 105,304 | $0 |
| 2023-09 | 0 | $0 | 18,000 | $189,054 | 18,000 | $131,310 |
| 2023-08 | 0 | $0 | 48,081 | $515,858 | 105,294 | $0 |
| 2023-05 | 0 | $0 | 16,834 | $170,762 | 36,971 | $0 |
| 2023-02 | 0 | $0 | 20,021 | $153,358 | 36,966 | $0 |
| 2022-11 | 0 | $0 | 4,898 | $26,643 | 14,191 | $0 |
| 2022-03 | 0 | $0 | 10,000 | $170,690 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-25 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 2,336 | 13.42 | 31,349 |
| 2025-08-25 | Sweeny Nicole (Chief Commercial Officer) | Sale | 1,480 | 13.42 | 19,861 |
| 2025-08-25 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 1,954 | 13.42 | 26,222 |
| 2025-08-22 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 2,942 | 13.22 | 38,902 |
| 2025-08-22 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 5,000 | .00 | 0 |
| 2025-08-22 | Sweeny Nicole (Chief Commercial Officer) | Sale | 1,864 | 13.22 | 24,647 |
| 2025-08-22 | Sweeny Nicole (Chief Commercial Officer) | Option Ex | 5,000 | .00 | 0 |
| 2025-08-22 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 2,362 | 13.22 | 31,232 |
| 2025-08-22 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 3,125 | .00 | 0 |
| 2025-08-22 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 10,940 | 13.22 | 144,659 |
| 2025-08-21 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 6,250 | .00 | 0 |
| 2025-08-21 | Sweeny Nicole (Chief Commercial Officer) | Option Ex | 6,250 | .00 | 0 |
| 2025-08-21 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 3,750 | .00 | 0 |
| 2025-08-21 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 23,250 | .00 | 0 |
| 2025-08-18 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 2,939 | 13.19 | 38,756 |
| 2025-08-18 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 2,649 | 13.19 | 34,932 |
| 2025-08-18 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 4,409 | 13.19 | 58,141 |
| 2025-08-17 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 6,446 | .00 | 0 |
| 2025-08-17 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 4,203 | .00 | 0 |
| 2025-08-17 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 9,362 | .00 | 0 |
| 2025-07-09 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 30,250 | 15.69 | 474,713 |
| 2025-07-09 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 32,979 | 15.69 | 517,539 |
| 2025-06-09 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 7,169 | 14.50 | 103,950 |
| 2025-06-06 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,625 | .00 | 0 |
| 2025-05-23 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 2,146 | 11.31 | 24,271 |
| 2025-05-23 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 1,926 | 11.31 | 21,781 |
| 2025-05-22 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 5,000 | .00 | 0 |
| 2025-05-22 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 3,125 | .00 | 0 |
| 2025-05-19 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 2,776 | 11.84 | 32,876 |
| 2025-05-19 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 2,600 | 11.84 | 30,791 |
| 2025-05-19 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 3,808 | 11.84 | 45,098 |
| 2025-05-17 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 6,447 | .00 | 0 |
| 2025-05-17 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 4,205 | .00 | 0 |
| 2025-05-17 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 9,364 | .00 | 0 |
| 2025-04-09 | Shah Nimish P | Buy | 25,000 | 9.42 | 235,500 |
| 2025-03-07 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 6,669 | 11.97 | 79,827 |
| 2025-03-06 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,625 | .00 | 0 |
| 2025-02-18 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 3,125 | 9.82 | 30,700 |
| 2025-02-18 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 2,601 | 9.82 | 25,552 |
| 2025-02-18 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 5,104 | 9.82 | 50,141 |
| 2025-02-17 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 6,447 | .00 | 0 |
| 2025-02-17 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 4,204 | .00 | 0 |
| 2025-02-17 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 9,363 | .00 | 0 |
| 2025-02-13 | Shah Nimish P | Buy | 61,700 | 9.33 | 575,661 |
| 2025-02-12 | Shah Nimish P | Buy | 100,000 | 9.23 | 923,000 |
| 2025-02-11 | Shah Nimish P | Buy | 26,703 | 9.18 | 245,133 |
| 2025-02-10 | Shah Nimish P | Buy | 4,137 | 9.14 | 37,812 |
| 2025-02-07 | Shah Nimish P | Buy | 73,649 | 9.29 | 684,199 |
| 2025-02-03 | Shah Nimish P | Buy | 14,562 | 9.22 | 134,261 |
| 2025-01-31 | Shah Nimish P | Buy | 11,754 | 8.89 | 104,493 |
| 2025-01-30 | Shah Nimish P | Buy | 43,707 | 8.76 | 382,873 |
| 2024-12-09 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 7,627 | 9.75 | 74,363 |
| 2024-12-06 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,625 | .00 | 0 |
| 2024-11-26 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 2,187 | 9.87 | 21,585 |
| 2024-11-26 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 1,963 | 9.87 | 19,378 |
| 2024-11-22 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 5,000 | .00 | 0 |
| 2024-11-22 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 3,125 | .00 | 0 |
| 2024-11-18 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 8,077 | 9.26 | 74,768 |
| 2024-11-18 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 7,192 | 9.26 | 66,576 |
| 2024-11-18 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 14,400 | 9.26 | 133,300 |
| 2024-11-17 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 18,531 | .00 | 0 |
| 2024-11-17 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 11,496 | .00 | 0 |
| 2024-11-17 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 30,198 | .00 | 0 |
| 2024-09-09 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 7,352 | 12.19 | 89,620 |
| 2024-09-06 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,625 | .00 | 0 |
| 2024-08-23 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 2,135 | 12.40 | 26,474 |
| 2024-08-23 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 1,916 | 12.40 | 23,758 |
| 2024-08-22 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 5,000 | .00 | 0 |
| 2024-08-22 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 3,125 | .00 | 0 |
| 2024-08-19 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 7,973 | 12.01 | 95,779 |
| 2024-08-19 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 7,102 | 12.01 | 85,316 |
| 2024-08-19 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 14,215 | 12.01 | 170,764 |
| 2024-08-17 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 18,528 | .00 | 0 |
| 2024-08-17 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 11,495 | .00 | 0 |
| 2024-08-17 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 30,195 | .00 | 0 |
| 2024-06-07 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 7,465 | 11.53 | 86,071 |
| 2024-06-06 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,625 | .00 | 0 |
| 2024-05-20 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 13,175 | 11.77 | 155,003 |
| 2024-05-20 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 11,610 | 11.77 | 136,591 |
| 2024-05-20 | Feener Edward P. (CHIEF SCIENTIFIC OFFICER) | Sale | 8,088 | 11.77 | 95,155 |
| 2024-05-20 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Sale | 21,959 | 11.77 | 258,347 |
| 2024-05-17 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 30,614 | .00 | 0 |
| 2024-05-17 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 18,789 | .00 | 0 |
| 2024-05-17 | Feener Edward P. (CHIEF SCIENTIFIC OFFICER) | Option Ex | 18,789 | .00 | 0 |
| 2024-05-17 | Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) | Option Ex | 51,031 | .00 | 0 |
| 2024-02-20 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Sale | 14,295 | 14.12 | 201,773 |
| 2024-02-20 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Sale | 12,053 | 14.12 | 170,128 |
| 2024-02-20 | Feener Edward P. (CHIEF SCIENTIFIC OFFICER) | Sale | 28,288 | 14.29 | 404,235 |
| 2024-02-20 | Crockett Thomas Andrew (CEO) | Sale | 24,888 | 14.12 | 351,294 |
| 2024-02-20 | Palleiko Benjamin L (CFO, CBO) | Sale | 22,802 | 14.12 | 321,850 |
| 2024-02-17 | Audhya Paul K. (CHIEF MEDICAL OFFICER) | Option Ex | 30,613 | .00 | 0 |
| 2024-02-17 | Yea Christopher (CHIEF DEVELOPMENT OFFICER) | Option Ex | 18,788 | .00 | 0 |
| 2024-02-17 | Feener Edward P. (CHIEF SCIENTIFIC OFFICER) | Option Ex | 18,788 | .00 | 0 |
| 2024-02-17 | Crockett Thomas Andrew (CEO) | Option Ex | 54,415 | .00 | 0 |
| 2024-02-17 | Palleiko Benjamin L (CFO, CBO) | Option Ex | 51,029 | .00 | 0 |
| 2024-02-14 | Feener Edward P. (CHIEF SCIENTIFIC OFFICER) | Sale | 28,171 | 15.01 | 422,818 |
| 2024-02-14 | Crockett Thomas Andrew (CEO) | Sale | 58,356 | 15.01 | 875,865 |
| 2024-02-14 | Palleiko Benjamin L (CFO, CBO) | Sale | 40,855 | 15.01 | 613,192 |
| 2024-02-08 | Shah Nimish P | Buy | 29,747 | 14.70 | 437,280 |
| 2024-02-07 | Shah Nimish P | Buy | 51,827 | 14.56 | 754,601 |
| 2024-02-06 | Shah Nimish P | Buy | 4,474 | 14.74 | 65,946 |
| 2024-02-01 | Crockett Thomas Andrew (CEO) | Sale | 10,000 | 16.50 | 164,950 |
| 2024-01-30 | Shah Nimish P | Buy | 88,099 | 14.47 | 1,274,792 |
| 2024-01-29 | Shah Nimish P | Buy | 80,600 | 14.22 | 1,146,132 |
| 2024-01-26 | Shah Nimish P | Buy | 4,174 | 12.98 | 54,178 |
| 2024-01-25 | Shah Nimish P | Buy | 7,030 | 12.73 | 89,491 |
| 2024-01-24 | Shah Nimish P | Buy | 20,686 | 12.44 | 257,333 |
| 2024-01-23 | Shah Nimish P | Buy | 10,897 | 12.54 | 136,648 |
| 2024-01-22 | Shah Nimish P | Buy | 67,546 | 12.55 | 847,702 |
| 2024-01-19 | Shah Nimish P (10% Owner) | Buy | 25,000 | 12.43 | 310,750 |
| 2024-01-18 | Shah Nimish P (10% Owner) | Buy | 39,680 | 12.51 | 496,396 |
| 2024-01-17 | Shah Nimish P (10% Owner) | Buy | 78,925 | 12.60 | 994,455 |
| 2024-01-16 | Shah Nimish P (10% Owner) | Buy | 19,599 | 12.73 | 249,495 |
| 2024-01-11 | Shah Nimish P (10% Owner) | Buy | 6,647 | 12.68 | 84,283 |
| 2024-01-11 | Feener Edward P. (Chief Scientific Officer) | Sale | 22,679 | 13.03 | 295,507 |
| 2024-01-10 | Shah Nimish P (10% Owner) | Buy | 47,700 | 12.67 | 604,359 |
| 2024-01-09 | Shah Nimish P (10% Owner) | Buy | 20,816 | 12.56 | 261,448 |
| 2024-01-09 | Feener Edward P. (Chief Scientific Officer) | Sale | 100 | 13.00 | 1,300 |
| 2024-01-08 | Shah Nimish P (10% Owner) | Buy | 69,184 | 12.44 | 860,648 |
| 2024-01-08 | Feener Edward P. (Chief Scientific Officer) | Sale | 17,221 | 13.01 | 223,993 |
| 2024-01-04 | Shah Nimish P (10% Owner) | Buy | 41,764 | 12.11 | 505,762 |
| 2024-01-03 | Shah Nimish P (10% Owner) | Buy | 17,605 | 12.20 | 214,781 |
| 2023-12-29 | Shah Nimish P (10% Owner) | Buy | 6,013 | 12.49 | 75,102 |
| 2023-12-28 | Shah Nimish P (10% Owner) | Buy | 471,490 | 12.50 | 5,893,625 |
| 2023-12-27 | Shah Nimish P (10% Owner) | Buy | 41,514 | 11.97 | 496,922 |
| 2023-12-27 | Crockett Thomas Andrew (CEO) | Sale | 30,000 | 12.02 | 360,450 |
| 2023-11-20 | Audhya Paul K. (Chief Medical Officer) | Sale | 7,985 | 8.23 | 65,708 |
| 2023-11-20 | Yea Christopher (Chief Development Officer) | Sale | 7,113 | 8.23 | 58,532 |
| 2023-11-20 | Feener Edward P. (Chief Scientific Officer) | Sale | 4,958 | 8.23 | 40,799 |
| 2023-11-20 | Crockett Thomas Andrew (CEO) | Sale | 14,807 | 8.23 | 121,846 |
| 2023-11-20 | Palleiko Benjamin L (President, CFO, CBO & Sec'y) | Sale | 13,008 | 8.23 | 107,042 |
| 2023-11-17 | Audhya Paul K. (Chief Medical Officer) | Option Ex | 18,530 | .00 | 0 |
| 2023-11-17 | Yea Christopher (Chief Development Officer) | Option Ex | 11,497 | .00 | 0 |
| 2023-11-17 | Feener Edward P. (Chief Scientific Officer) | Option Ex | 11,497 | .00 | 0 |
| 2023-11-17 | Crockett Thomas Andrew (CEO) | Option Ex | 33,583 | .00 | 0 |
| 2023-11-17 | Palleiko Benjamin L (President, CFO, CBO & Sec'y) | Option Ex | 30,197 | .00 | 0 |
| 2023-09-11 | Cha Albert (Director) | Sale | 18,000 | 10.50 | 189,054 |
| 2023-09-11 | Cha Albert (Director) | Option Ex | 18,000 | 7.29 | 131,310 |
| 2023-08-18 | Audhya Paul K. (Chief Medical Officer) | Sale | 8,020 | 10.73 | 86,046 |
| 2023-08-18 | Yea Christopher (Chief Development Officer) | Sale | 7,142 | 10.73 | 76,626 |
| 2023-08-18 | Feener Edward P. (Chief Scientific Officer) | Sale | 4,976 | 10.73 | 53,387 |
| 2023-08-18 | Crockett Thomas Andrew (CEO) | Sale | 14,876 | 10.73 | 159,604 |
| 2023-08-18 | Palleiko Benjamin L (President, CFO, CBO & Sec'y) | Sale | 13,067 | 10.73 | 140,195 |
| 2023-08-17 | Audhya Paul K. (Chief Medical Officer) | Option Ex | 18,529 | .00 | 0 |
| 2023-08-17 | Yea Christopher (Chief Development Officer) | Option Ex | 11,494 | .00 | 0 |
| 2023-08-17 | Feener Edward P. (Chief Scientific Officer) | Option Ex | 11,494 | .00 | 0 |
| 2023-08-17 | Crockett Thomas Andrew (CEO) | Option Ex | 33,582 | .00 | 0 |
| 2023-08-17 | Palleiko Benjamin L (President, CFO, CBO & Sec'y) | Option Ex | 30,195 | .00 | 0 |
| 2023-05-18 | Audhya Paul K. (Chief Medical Officer) | Sale | 2,780 | 10.14 | 28,200 |
| 2023-05-18 | Yea Christopher (Chief Development Officer) | Sale | 2,604 | 10.14 | 26,414 |
Insider trading activities including stock purchases, stock sales, and option exercises of KALV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kalvista Pharmaceuticals, Inc. (symbol KALV, CIK number 1348911) see the Securities and Exchange Commission (SEC) website.